Treatment Intensification after Glucagon-Like Peptide-1 Receptor Agonists Therapy in Type 2 Diabetes-The RESTORE-G Real-World Study

被引：0
|
作者：
Candido, Riccardo
Nicolucci, Antonio
Larosa, Monica
Rossi, Maria Chiara
Napoli, Raffaele
机构：
来源：
DIABETES | 2022年 / 71卷
关键词：
D O I：
10.2337/db22-87-LB
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
87-LB
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Advantages of glucagon-like peptide-1 receptor agonists in the treatment of patients with type 2 diabetes mellitus: A review
    Demidova, Tatiana Yu.
    Titova, Victoria V.
    Izmaylova, Maryam Ya.
    TERAPEVTICHESKII ARKHIV, 2023, 95 (10) : 876 - 880
  • [42] Emerging New Therapies for the Treatment of Type 2 Diabetes Mellitus: Glucagon-like Peptide-1 Receptor Agonists
    Lindamood, Christopher A.
    Taylor, James R.
    CLINICAL THERAPEUTICS, 2015, 37 (03) : 483 - 493
  • [43] DIABETES AND OBESITY. THE ROLE OF AGONISTS GLUCAGON-LIKE PEPTIDE-1 OF IN THE TREATMENT OF TYPE 2 DIABETES
    Petunina, Nina A.
    Telnova, Milena E.
    DIABETES MELLITUS, 2018, 21 (04): : 293 - 300
  • [44] Effectiveness and safety of glucagon-like peptide 1 receptor agonists in patients with type 2 diabetes: evidence from a retrospective real-world study
    Jiang, Yan
    Bai, Han-Sheng
    Liu, Guo-Xin
    Wang, Shi-Yi
    Yin, Li
    Hou, Zhao-Ting
    Zhao, Chen-Yang
    Fan, Guang-Jun
    FRONTIERS IN ENDOCRINOLOGY, 2024, 15
  • [45] Glucagon-like peptide-1 receptor agonists as add-on therapy to insulin for type 1 diabetes mellitus
    Tan, Xinrui
    Pan, Xiongfeng
    Wu, Xiaochuan
    Zheng, Songjia
    Chen, Yuyao
    Liu, Donghai
    Zhang, Xingxing
    FRONTIERS IN PHARMACOLOGY, 2023, 14
  • [46] Real-world weight-loss effectiveness of glucagon-like peptide-1 agonists among patients with type 2 diabetes: A retrospective cohort study
    White, Gretchen E.
    Shu, Ingrid
    Rometo, David
    Arnold, Jon
    Korytkowski, Mary
    Luo, Jing
    OBESITY, 2023, 31 (02) : 537 - 544
  • [47] Glucagon-like peptide-1 therapy for youth with type 2 diabetes
    Cho, Young Min
    JOURNAL OF DIABETES INVESTIGATION, 2023, 14 (03) : 362 - 363
  • [48] Differential Risk of Cancer Associated with Glucagon-like Peptide-1 Receptor Agonists: Analysis of Real-world Databases
    Wang, Jiasheng
    Kim, Chang H.
    ENDOCRINE RESEARCH, 2022, 47 (01) : 18 - 25
  • [49] Glucagon-like peptide-1 receptor agonists to treat chronic liver disease: real-world evidence or ambiguity?
    Suissa, Samy
    Hernaez, Ruben
    GUT, 2024, 73 (05) : 721 - 724
  • [50] Glucagon-like peptide-1 receptor agonists and type 1 diabetes: a potential game changer?
    Resnick, Ortal
    Bril, Fernando
    Beauchamp, Giovanna
    FRONTIERS IN ENDOCRINOLOGY, 2025, 15
12345